Novel lung function tests can improve phenotyping and differential therapy in COPD

F. Trinkmann (Mannheim, Germany), J. Gawlitza (Mannheim, Germany), J. Schäfer (Mannheim, Germany), M. Schroeter (Mannheim, Germany), J. Drayß (Mannheim, Germany), J. Michels (Mannheim, Germany), M. Borggrefe (Mannheim, Germany), I. Akin (Mannheim, Germany), J. Saur (Mannheim, Germany)

Source: International Congress 2019 – COPD clinical studies: bronchodilators, corticosteroids and more
Session: COPD clinical studies: bronchodilators, corticosteroids and more
Session type: Poster Discussion
Number: 3379

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Trinkmann (Mannheim, Germany), J. Gawlitza (Mannheim, Germany), J. Schäfer (Mannheim, Germany), M. Schroeter (Mannheim, Germany), J. Drayß (Mannheim, Germany), J. Michels (Mannheim, Germany), M. Borggrefe (Mannheim, Germany), I. Akin (Mannheim, Germany), J. Saur (Mannheim, Germany). Novel lung function tests can improve phenotyping and differential therapy in COPD. 3379

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: